Geode Capital Management
GUTS icon

Geode Capital Management’s Fractyl Health GUTS Stock Holding History

Geode Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.05M Sell
109,695
-9,910
-8% -$84.7K ﹤0.01% 3349
2026
Q1 		$657K Buy
119,605
+14,284
+14% +$158K ﹤0.01% 3488
2025
Q4 		$2.78M Buy
105,321
+80,742
+328% +$1.56M ﹤0.01% 3046
2025
Q3 		$469K Buy
24,579
+15,372
+167% +$239K ﹤0.01% 3647
2025
Q2 		$179K Sell
9,207
-33,748
-79% -$654K ﹤0.01% 3908
2025
Q1 		$613K Buy
42,955
+198
+0.5% +$3.79K ﹤0.01% 3472
2024
Q4 		$1.06M Buy
42,757
+967
+2% +$27K ﹤0.01% 3358
2024
Q3 		$1.27M Buy
41,790
+26,112
+167% +$1.02M ﹤0.01% 3274
2024
Q2 		$803K Buy
15,678
+7,559
+93% +$584K ﹤0.01% 3393
2024
Q1 		$721K Buy
+8,119
New +$820K ﹤0.01% 3483

Other funds holding GUTS

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Catalio Capital Management
Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Pale Fire Capital SE
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
General Catalyst Group Management
General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return
Deer Management Company
Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
M28 Capital Management
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management's GUTS Position: Q2 2026 in Review

Geode Capital Management reduced its Fractyl Health (GUTS) stake by 8.3% in Q2 2026, selling an estimated $84.7K and leaving 109,695 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

Geode Capital Management first reported a position in GUTS in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.78M in Q4 2025. 79 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Geode Capital Management held 109,695 shares of Fractyl Health worth $1.05M as of Q2 2026.
  • Geode Capital Management sold 9,910 Fractyl Health shares in Q2 2026, an estimated $84.7K.
  • Fractyl Health made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3349 holding.
  • Geode Capital Management first reported a position in Fractyl Health in Q1 2024 and has held it in 10 quarters since.
  • Geode Capital Management's Fractyl Health position peaked at $2.78M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.